The largest database of trusted experimental protocols

Anti brdu fitc

Manufactured by BioLegend

Anti-BrdU-FITC is a fluorescent-labeled antibody that binds to bromodeoxyuridine (BrdU), a synthetic nucleoside analog of thymidine. This product is used in flow cytometric analysis to detect and quantify cells that have incorporated BrdU during DNA synthesis, which is indicative of cell proliferation.

Automatically generated - may contain errors

7 protocols using anti brdu fitc

1

Bone Marrow Progenitor Cell Proliferation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bone marrow cells were isolated from WD-fed WT or Apoe−/− mice treated with vehicle or TG101348 (240 mg/day) for 6 weeks and then were cultured in IMDM (Invitrogen) with 10% FBS and 1 μM BrdU (Sigma). After 12-h incubation, cells were stained as described above (lineage changed to APC-conjugated and CD34 changed to PE-conjugated antibodies) for progenitor cells together with FITC-anti BrdU (Biolegend). Proliferation was quantified as percentage of BrdU + cells by flow cytometry.
+ Open protocol
+ Expand
2

Antibody Characterization for Cell Signaling Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies used in this study are as follows. Anti-human Claspin was generated against the human recombinant Claspin with aa896–1,014 produced in E. coli. Anti-Chk1 phospho-S345 (#2348), anti-Chk1 phospho-S317 (#2344), anti-p44/42 MAPK (Erk1/2) (#4695), anti- SAPK/JNK (#9252), p38 MAPK (#8690), anti-p38 MAPK T180/Y182 (#4511), anti-p44/42 MAPK (Erk1/2) T202/Y204 (#4370), anti-SAPK/JNK T183/Y185 (#4668), Caspase-9 (#9508), Cleaved Caspase-3(#9661), and Mcl-1 (#5453) were obtained from Cell Signaling. Anti-α Tubulin (sc23948), anti-MCM2 (sc-9839), and anti-Chk1 (sc-8408) were obtained from Santa Cruz. Anti-phospho-H2A.X S139 (06-536) was purchased from Merck. Anti-BrdU (Ab6326) was purchased from Abcam. Anti-ATR phospho-T1989 (GTX128145) was purchased from GeneTex. Anti-BrdU (555627) was purchased from BD Pharmingen. Anti-H2A.X phospho-S139 (613402), anti-Rat IgG Alexa Fluor 555 (405420), and FITC-Anti-BrdU (364104) were purchased from Biolegend. RPA32 phospho-S4/S8 (A300-245A) and anti-MCM2 S53(A300-756A) were purchased from Bethyl. Anti-Mouse IgG Alexa Fluor 488 (A-11017) was purchased from Invitrogen. Goat Anti-Rabbit IgG HRP (111-035-003) and Goat Anti-Mouse IgG (115-035-003) were purchased from Jackson ImmunoResearch Laboratory.
+ Open protocol
+ Expand
3

Analyzing Bone Marrow Progenitor Proliferation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bone marrow cells were isolated from WD-fed WT or Apoe−/− mice treated with vehicle or TG101348 (240 mg/day) for 6 weeks and then were cultured in IMDM(Invitrogen) with 10% FBS and 1μM BrdU (Sigma). After 12 hours incubation, cells were stained as described above (Lineage changed to APC conjugated and CD34 changed to PE conjugated antibodies) for progenitor cells together with FITC-anti BrdU (Biolegend). Proliferation was quantified as percentage of BrdU+ cells by flow cytometry.
+ Open protocol
+ Expand
4

Multiparameter Flow Cytometry Staining

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell staining was performed at 4°C with Fc Block (hybridoma 2.4G2) in FACS staining buffer (0.5% FBS and 0.1% NaN3 in dPBS). Anti–B220-FITC, anti–B220-PE, anti–CD21-APC, Annexin V-FITC, anti–BrdU-FITC, and Streptavidin-PE were purchased from BioLegend. Anti–CD23-biotin and anti–CD138-biotin were purchased from BD. Anti–CD69-biotin, anti–MHC-II-PE, and anti–TLR9-FITC were purchased from eBioscience. Flow data were acquired by the FACSCanto II (BD) and analyzed by FlowJo software.
+ Open protocol
+ Expand
5

Cell Cycle Analysis by BrdU-PI Staining

Check if the same lab product or an alternative is used in the 5 most similar protocols
To analyze cell cycle distribution, bromodeoxyuridine (BrdU) – propidium iodide (PI) staining was performed. Briefly, cells were plated at 7.5 × 104 cells per 6-well plate (7800/cm2), and allowed to attach overnight. Once attached, media was replaced and cells were then treated with vehicle control (DMSO) or RAGE inhibitors at 1 µM for 48 h. During the final hour of culture, cells were pulsed with 10 µM BrdU (BioLegend Catalog# 423401), collected by trypsinization, fixed in iced-cold 70% ethanol, and stored at −20C for at least 2 h. Fixed cells were labeled with anti-BrdU-FITC (BioLegend Catalog# 364104) following manufacturer’s instructions, and counterstained with propidium iodide (p4170-25MG Sigma). Labeled cells were analyzed by flow cytometry (BD Fortessa), and results analyzed using FlowJo software.
+ Open protocol
+ Expand
6

Cell Cycle Analysis by BrdU and PI

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded in 60 mm dishes (Corning 430166) (75,000 cells/well) and treated with vehicle or drugs 24 h later. Following the indicated drug exposure times, the cells were pulsed with 10 μM bromodeoxyuridine (BrdU; Sigma) for 90 min, trypsinized, washed with 1x PBS, fixed in ice-cold 70% ethanol, denatured with 2 N HCl for 25 min at RT, followed by inactivation with 0.1 M sodium borate, pH 8.5. Cells were then incubated with anti-BrdU FITC (Biolegend, Clone 3D4, 364104) (5 μl in 100 μl cells suspended in 0.2% BSA in PBS) for 20 min at RT, spun down then resuspended in 500 μl PI/RNase staining buffer (BD Biosciences, 550825) for 15 min both in the dark. Cell cycle analysis was performed on a FACSCalibur cytometer/CellQuest Pro.
+ Open protocol
+ Expand
7

Quantifying Neutrophil Proliferation In Vivo

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were injected (i.p.) with 2.5 mg of BrdU (Thermo Fisher, #000103) (Figure S3). Neutrophils containing BrdU that were present in the mouse PB and lung samples were detected using an anti-BrdU antibody. Briefly, single-cell suspensions from PB and lung tissues were first stained for cell surface antigens (CD45-APC/Cy7, CD11b-PE/Cy7, Ly-6G-APC, and CD62L-PE), and then fixed and permeabilized using a BrdU Flow Kit (BD Bioscience, #557891). Cells were treated with DNase I (Sigma-Aldrich, 100 μg/mL, #D5025) for 1 h at 37°C to expose BrdU incorporated in DNA. Then, cells were stained for BrdU with fluorescent antibodies (anti-BrdU-FITC, Biolegend, #364103).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!